We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Next Generation of Rapid Diagnostic Assays Will Combine Disposable Test Materials with Smartphone Applications

By LabMedica International staff writers
Posted on 26 Apr 2015
The new generation of rapid diagnostic tests will reflect advances in both materials sciences and instant communications via the Internet and social media.

Current diagnostic assays commonly require long assay time, sophisticated infrastructure, and expensive reagents that are not compatible with resource-constrained and geographically isolated settings. More...
While paper and flexible material-based platform technologies provide alternative approaches for the development of point-of-care (POC) diagnostic assays for broad applications in medicine, they lack the capability of transferring test results to a central location.

Investigators at Florida Atlantic University (Boca Raton, USA), Stanford University (Palo Alto, CA, USA), and Harvard University (Cambridge, MA, USA) have been working to integrate cellulose paper and flexible polyester film-based assays with dedicated smartphone applications.

In a recently published paper, the investigators presented a snapshot of the current state of the art. They described the use of three different paper and flexible material-based platforms with embedded electrical and optical sensing modalities to develop tests for the selective and accurate capture and detection of multiple biological targets. Finger prick volume equivalents of biological specimens such as whole blood, plasma, and peritoneal dialysis effluent were tested. Viruses (Human immunodeficieny virus 1), bacteria (Escherichia coli and Staphylococcus aureus), and cells (CD4+ T lymphocytes) were identified with clinically relevant levels of detection and sensitivity. A smartphone application was developed that allowed images of the test results to be sent from a cellular telephone for analysis anywhere in the world.

"The future of diagnostics and health monitoring will have potentially cell-phone based or portable readers sipping saliva or blood and continuously monitoring human health taking it way beyond where we are with counting steps today," said senior author Dr. Uktan Demirci, associate professor of radiology at Stanford University.

The paper was published in the March 6, 2015, online edition of the journal Nature Scientific Reports.

Related Links:

Florida Atlantic University
Stanford University
Harvard University



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.